Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models.
| Autor: | Ting-Yu Chang1, Yan Yan2, Zih-Yao Yu1, Rathore, Moeez2,3, Nian-Zhe Lee1, Hui-Ju Tseng1, Li-Hsin Cheng4,5, Wei-Jan Huang6, Wei Zhang2,3, Chan, Ernest R.7, Yulan Qing2, Ming-Lun Kang8, Rui Wang2,3, Tsai, Kelvin K.4,5, Pink, John J.2, Harte, William E.9, Gerson, Stanton L.2,10 slg5@case.edu, Sung-Bau Lee1 sbl@tmu.edu.tw |
|---|---|
| Zdroj: | Journal of Clinical Investigation. 12/2/2024, Vol. 134 Issue 23, p1-17. 17p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|